176 related articles for article (PubMed ID: 2832444)
1. Intracoronary infusion of dobutamine to patients with and without severe congestive heart failure. Dose-response relationships, correlation with circulating catecholamines, and effect of phosphodiesterase inhibition.
Colucci WS; Denniss AR; Leatherman GF; Quigg RJ; Ludmer PL; Marsh JD; Gauthier DF
J Clin Invest; 1988 Apr; 81(4):1103-10. PubMed ID: 2832444
[TBL] [Abstract][Full Text] [Related]
2. In vivo studies of myocardial beta-adrenergic receptor pharmacology in patients with congestive heart failure.
Colucci WS
Circulation; 1990 Aug; 82(2 Suppl):I44-51. PubMed ID: 2164896
[TBL] [Abstract][Full Text] [Related]
3. Beta-adrenergic inotropic responsiveness of patients with heart failure: studies with intracoronary dobutamine infusion.
Colucci WS; Leatherman GF; Ludmer PL; Gauthier DF
Circ Res; 1987 Oct; 61(4 Pt 2):I82-6. PubMed ID: 3652407
[TBL] [Abstract][Full Text] [Related]
4. Observations on the intracoronary administration of milrinone and dobutamine to patients with congestive heart failure.
Colucci WS
Am J Cardiol; 1989 Jan; 63(2):17A-22A. PubMed ID: 2909993
[TBL] [Abstract][Full Text] [Related]
5. Milrinone and dobutamine in severe heart failure: differing hemodynamic effects and individual patient responsiveness.
Colucci WS; Wright RF; Jaski BE; Fifer MA; Braunwald E
Circulation; 1986 Mar; 73(3 Pt 2):III175-83. PubMed ID: 3510774
[TBL] [Abstract][Full Text] [Related]
6. Phosphodiesterase III inhibition or adrenoreceptor stimulation: milrinone as an alternative to dobutamine in the treatment of severe heart failure.
Mager G; Klocke RK; Kux A; Höpp HW; Hilger HH
Am Heart J; 1991 Jun; 121(6 Pt 2):1974-83. PubMed ID: 1852090
[TBL] [Abstract][Full Text] [Related]
7. Positive inotropic and vasodilator actions of milrinone in patients with severe congestive heart failure. Dose-response relationships and comparison to nitroprusside.
Jaski BE; Fifer MA; Wright RF; Braunwald E; Colucci WS
J Clin Invest; 1985 Feb; 75(2):643-9. PubMed ID: 3973022
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of milrinone and dobutamine on right ventricular preload, afterload and systolic performance in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy.
Eichhorn EJ; Konstam MA; Weiland DS; Roberts DJ; Martin TT; Stransky NB; Salem DN
Am J Cardiol; 1987 Dec; 60(16):1329-33. PubMed ID: 3687783
[TBL] [Abstract][Full Text] [Related]
9. Comparative efficacy of short-term intravenous infusions of milrinone and dobutamine in acute congestive heart failure following acute myocardial infarction. Milrinone-Dobutamine Study Group.
Karlsberg RP; DeWood MA; DeMaria AN; Berk MR; Lasher KP
Clin Cardiol; 1996 Jan; 19(1):21-30. PubMed ID: 8903534
[TBL] [Abstract][Full Text] [Related]
10. Myocardial and vascular actions of milrinone.
Colucci WS
Eur Heart J; 1989 Aug; 10 Suppl C():32-8. PubMed ID: 2680495
[TBL] [Abstract][Full Text] [Related]
11. [The hemodynamic effects of the combination of milrinone in heart failure refractory to treatment with dopamine, dobutamine and/or nitroprusside].
Domínguez de Rozas JM; Guindo Soldevila J; Rodríguez Font E; Martínez Vílchez R
Rev Esp Cardiol; 1994 Oct; 47(10):682-6. PubMed ID: 7991922
[TBL] [Abstract][Full Text] [Related]
12. Systemic and coronary effects of intravenous milrinone and dobutamine in congestive heart failure.
Grose R; Strain J; Greenberg M; LeJemtel TH
J Am Coll Cardiol; 1986 May; 7(5):1107-13. PubMed ID: 3958369
[TBL] [Abstract][Full Text] [Related]
13. Effects of beta-adrenergic stimulation with dobutamine on isovolumic relaxation in the normal and failing human left ventricle.
Parker JD; Landzberg JS; Bittl JA; Mirsky I; Colucci WS
Circulation; 1991 Sep; 84(3):1040-8. PubMed ID: 1653121
[TBL] [Abstract][Full Text] [Related]
14. Milrinone, dobutamine, and nitroprusside: comparative effects on hemodynamics and myocardial energetics in patients with severe congestive heart failure.
Monrad ES; Baim DS; Smith HS; Lanoue AS
Circulation; 1986 Mar; 73(3 Pt 2):III168-74. PubMed ID: 3510773
[TBL] [Abstract][Full Text] [Related]
15. Effects of milrinone on systemic hemodynamics and regional circulations in dogs with congestive heart failure: comparison with dobutamine.
Liang CS; Thomas A; Imai N; Stone CK; Kawashima S; Hood WB
J Cardiovasc Pharmacol; 1987 Nov; 10(5):509-16. PubMed ID: 2447398
[TBL] [Abstract][Full Text] [Related]
16. Role of nitric oxide in parasympathetic modulation of beta-adrenergic myocardial contractility in normal dogs.
Hare JM; Keaney JF; Balligand JL; Loscalzo J; Smith TW; Colucci WS
J Clin Invest; 1995 Jan; 95(1):360-6. PubMed ID: 7529262
[TBL] [Abstract][Full Text] [Related]
17. Comparison of intravenous milrinone and dobutamine for congestive heart failure secondary to either ischemic or dilated cardiomyopathy.
Biddle TL; Benotti JR; Creager MA; Faxon DP; Firth BG; Fitzpatrick PG; Konstam MA; Krebs C; Walton L; Kershner RP
Am J Cardiol; 1987 Jun; 59(15):1345-50. PubMed ID: 3591689
[TBL] [Abstract][Full Text] [Related]
18. The inotropic and hemodynamic effects of intravenous milrinone when reflex adrenergic stimulation is suppressed by beta-adrenergic blockade.
Travill CM; Pugh S; Noble MI
Clin Ther; 1994; 16(5):783-92. PubMed ID: 7859237
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide inhibits the positive inotropic response to beta-adrenergic stimulation in humans with left ventricular dysfunction.
Hare JM; Loh E; Creager MA; Colucci WS
Circulation; 1995 Oct; 92(8):2198-203. PubMed ID: 7554202
[TBL] [Abstract][Full Text] [Related]
20. [Additive effects of milrinone and dobutamine in severe heart failure].
Meissner A; Herrmann G; Gerdesmeyer L; Simon R
Z Kardiol; 1992 May; 81(5):266-71. PubMed ID: 1621407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
